The nuclear factor kappa B (NF-κB) signaling pathway is downstream of CXCL12/CXCR4, modulating breast cancer progression along with inflammation, cell proliferation, migration, and invasion [17,18]. This evidence concerns the gene CXCL12 and breast carcinoma.